2022 Speaker Faculty Andrea Galbiati Research Scientist Philochem Cari Meisel Director of Research & Development NanoTomer Neil Bander Professor Weill Cornell - Cornell University Robert Huang Founder & Chief Executive Officer Coherent Biopharma Christian Marsolais Chief Medical Officer & Vice President of Medical Affairs Theratechnologies Christina McGuire Senior Scientist Guardian Therapeutics David Owen Vice President Research & Development Starpharma Edward Barnes Technical Director Aptamer Group Fu-An Kang Vice President Research miRecule Gavin Bennet Head of Pre-Clinical Development Bicycle Therapeutics Gordon Rigg Principal Consultant Apex Biologics Consulting Hans Georg Lerchen Chief Scientific Officer Vincerx Pharma Jarrod Longcor Chief Business Officer & SVP of Operations Cellectar Biosciences John Flygare Senior Principal Scientist Merck Mahendra Deonorain Chief Executive Officer, Chief Science & Operating Officer Antikor Biopharma Nicolas Camper Senior Director, Chemistry Abzena Michael Alonso Vice President of Immunology & Pharmacology Bolt Biotherapeutics Mike Wheatcroft Chief Scientist Telix Pharmaceuticals Mingchao Kang Project Leader, EuCode Ambrx Nick Yoder Direction, Bioconjugation Magenta Therapeutics Ramana Doppalapudi Vice President of Chemistry Avidity Biosciences Ruben Postel Founder & Chief Scientific Officer Sapreme Technologies Shelley Ackerman Associate Director & Project Team Lead Bolt Biotherapeutics Thomas Tulip, PhD Chief Technology Officer Radiopharm Theranostics Gregory Adams Chief Scientific Officer Elucida Oncology Inc. Timothy Weeden Senior Director & Head of Platform Development Dyne Therapeutics Yi-Shen Zhu Professor Nanjing Tech University Zhibo Lui Principal Investigator Peking University